An FDA advisory committee voted 8-4 Thursday, November 8, in favor of approval of a new ultra-long-acting insulin Tresiba and its mixed insulin Ryzodeg for type 1 and type 2 diabetes….
Read More »Benefits of Weight Loss in Diabetes Questioned
Obese people with diabetes who lost weight didn’t lower their risk of having a heart attack or stroke….
Read More »First Possible Non-Invasive Continuous Glucose Monitor Approved in Europe
C8 MediSensors, Inc. has received Europe’s CE Mark approval for its Optical Non-Invasive CGM System….
Read More »Patients Searching Internet for Info on Their Docs
Physicians who don’t manage their online presence run the risk of failing to attract new patients….
Read More »Eleven, Yes Eleven Minutes a Day, Really
Middle-aged people who walk briskly for as little as 75 minutes per week may live 1.8 years longer, even if they are overweight….
Read More »Diabetes Deaths Fall 61%
According to the CDC, the death rate from diabetes among children and adolescents has fallen by more than 60% since the late 1960s….
Read More »Major Entitlement Savings from Advances in Diabetes Research
More than one-half trillion dollars in savings to Medicare and the overall economy is possible if….
Read More »Nephropathy Progression Reduced with Bilirubin
Treatments raising serum bilirubin levels may protect against diabetic nephropathy….
Read More »High-protein Diets Work
Participants who were on a high-protein diet lost 1.8 extra pounds and more body fat at 12 weeks compared with those on a standard-protein diet….
Read More »New Simpler C-Peptide Test Available
A single blood test measuring C-peptide at 90 minutes after a mixed-meal challenge was a sensitive and specific measure of endogenous insulin secretion among children with new-onset type 1 diabetes….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.